Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Infographic: A.I. Getting Hype, But Fewer Venture Funds

Bar chart: Venture funding in artificial intelligence by quarter, 2019 to 2023

According to CB Insights, venture investments in A.I. are declining each quarter in 2023, with the number of venture deals reaching a low level not seen since 2017. . . . → Read More: Infographic: A.I. Getting Hype, But Fewer Venture Funds

Lab-Grown Tissue Company Gains $38M in Seed Funds

Andrei Georgescu and Dan Huh in the lab

A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding. . . . → Read More: Lab-Grown Tissue Company Gains $38M in Seed Funds

Start-Up Developing Precision Antibiotics for Resistant Bacteria

Pseudomonas Aeruginosa bacteria

A company formed earlier this year is developing precision treatments for bacteria resistant to conventional antibiotics, and raising £4.3 million ($US 5.4 million) in seed funds. . . . → Read More: Start-Up Developing Precision Antibiotics for Resistant Bacteria

Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds

Adeno-associated virus

A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round. . . . → Read More: Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds

Infographic – Digital Health Funding Continues Slide

Bar chart: Digital health venture funding by quarter, 2019 through 2023

Venture funding for digital health start-ups continued heading down in the third quarter of 2023, reaching low levels not seen in almost a decade. . . . → Read More: Infographic – Digital Health Funding Continues Slide

Life Science Incubator Gains $100M in Start-Up Funds

Raven in a tree

A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant. . . . → Read More: Life Science Incubator Gains $100M in Start-Up Funds

Start-Up Adapts Crispr for Molecular Detection, Raises $40M

Crispr graphic

A new company is underway that says it adapts the gene editing technique Crispr to make detecting nucleic acid targets like DNA or RNA faster and simpler. . . . → Read More: Start-Up Adapts Crispr for Molecular Detection, Raises $40M

Infographic – Q3 Life Science Venture Funds Tick Up

Bar chart: U.S. life science venture funding by quarter, 2013 to 2023

Venture investments in U.S. life science and biotechnology start-ups in the third quarter of 2023 rose from the previous two quarters to reach pre-pandemic levels. . . . → Read More: Infographic – Q3 Life Science Venture Funds Tick Up

Longevity Science Group Spins-Off Biotech Start-Up

Naked mole rat on black background

An organization funding research on extending the human life span by preventing age-related diseases is founding its first biotechnology company. . . . → Read More: Longevity Science Group Spins-Off Biotech Start-Up

Neuro Disease Biotech Gains $61M in Early Funds

Brain cell networks

A developer of treatments for Alzheimer’s disease that seeks to improve the condition of the brain’s support cells is raising £48 million ($US 61 million) in its first venture round. . . . → Read More: Neuro Disease Biotech Gains $61M in Early Funds